Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class ASSE: 600671

Announcement on Reply to the Information Disclosure Regulatory Letter on the Report for Q3 2024

· Issued by Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A via Shanghai Stock Exchange
Announcement on Reply to the Information Disclosure Regulatory Letter on the Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment